tradingkey.logo
tradingkey.logo
Search

Co-Diagnostics Inc

CODX
Add to Watchlist
0.970USD
+0.030+3.19%
Market hours 09/18, 11:41ET
4.73MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+3.19%

5 Days

-11.82%

1 Month

-27.61%

6 Months

-57.64%

Year to Date

-80.87%

1 Year

-92.25%

Key Figures

0.953Open
0.989High
21.99KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.45%Turnover Ratio
0.940Prev. Close
0.906Low
21.32KTurnover
LossP/E Static
0.37P/B
0.00%Div Yield TTM
-128.83%ROA
13.54052wk High
0.14Volume Ratio
-37.64MNet Profit
4.88MShares
-1054.6482EPS TTM
2.91Beta
-154.38%ROE
0.90652wk Low
8.83%Amplitude
-123.13%Gross Margin
4.73MMarket Cap
-3.25Reward/Risk
202.88%Risk Rate
Recent
Earnings
Transcripts
More news coming soon, stay tuned...

Co-Diagnostics Inc's Score

0.01vs previous score
Forecast8.00
Financial Health5.99
Technical4.99
Valuation Dimensions1.00
Institutional Confidence3.00
Risk Assessment1.71

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
4.000Target Price
+69.49%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy00000000
Buy11000000
Hold01222222
Sell00000000
Strong Sell00000000

Co-Diagnostics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Sell

Summary

Sell

Moving Average

Strong sell

Co-Diagnostics Inc Latest Earnings Call Transcripts

Co-Diagnostics (CODX) Q2 2026 Earnings Call: FDA Filing Advances as Cash Falls

Co-Diagnostics Q2 2026 revenue reached $166,000 as losses narrowed, while CODX filed its flu and RSV assay with the FDA and ended with $3.6 million in cash.

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-1.46/-3.00
Revenue / Forecast
166.13K/166.50K

Co-Diagnostics Inc Profile

SectorHealthcare Equipment & Supplies
Ticker SymbolCODX
Number of employees132
CountryUnited States of America

Ownership

ShareholdersProportion
Orca Capital GmbH1.74%
Private Advisory Group LLC1.15%
Egan (Dwight H.)0.82%
Renaissance Technologies LLC0.68%
Shareholder TypesProportion
Investment Advisor3.59%
Individual Investor3.39%
Hedge Fund0.72%
Investment Advisor/Hedge Fund0.56%

FAQs

What is the current price of Co-Diagnostics Inc (CODX)?

The current price of Co-Diagnostics Inc (CODX) is 0.94.

What is the symbol of Co-Diagnostics Inc?

The ticker symbol of Co-Diagnostics Inc is CODX.

What is the 52-week high of Co-Diagnostics Inc?

The 52-week high of Co-Diagnostics Inc is 13.54.

What is the 52-week low of Co-Diagnostics Inc?

The 52-week low of Co-Diagnostics Inc is 4.98.

What is the market capitalization of Co-Diagnostics Inc?

The market capitalization of Co-Diagnostics Inc is 4.61M.

Is Co-Diagnostics Inc (CODX) currently rated as Buy, Hold, or Sell?

According to analysts, Co-Diagnostics Inc (CODX) has an overall rating of Buy, with a price target of 4.00.

What is the Earnings Per Share (EPS TTM) of Co-Diagnostics Inc (CODX)?

The Earnings Per Share (EPS TTM) of Co-Diagnostics Inc (CODX) is -1054.65.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.